Dr. Seedor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
925 Chestnut Street, Suite 320 A
Philadelphia, PA 19107Phone+1 215-955-8874Fax+1 215-503-2715- Is this information wrong?
Summary
- I am a medical oncologist specializing in cutaneous and ocular melanoma as well as non-melanoma skin cancers. I completed my medical school and residency training at Jefferson, and then completed my hematology/oncology training at Fox Chase Cancer Center/Temple University Hospital.
Education & Training
- Temple University Hospital/Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2021
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2015 - 2018
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2015
Certifications & Licensure
- DE State Medical License Current
- NJ State Medical License 2022 - 2025
- PA State Medical License 2015 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 5 citationsTreatment of Metastatic Melanoma in the Elderly.Rino S Seedor, Marlana Orloff> ;Current Oncology Reports. 2022 Jul 1
- Prospective Comparison of Geriatric Assessment and Provider's Assessment of Older Adults With Metastatic Breast Cancer in the Community.Rino S Seedor, Caitlin R Meeker, Bianca Lewis, Elizabeth A Handorf, Kelly A Filchner, Ramya Varadarajan, Jack Hensold, Aruna Padmanabhan, Benjamin Negin, Kenneth Blank...> ;The Oncologist. 2022 Mar 4
- 4 citationsReview of bi-specific therapies in uveal melanoma.Marlana Orloff, Rino Seedor, Takami Sato> ;Cancer Gene Therapy. 2022 Dec 1
- Join now to see all
Journal Articles
- Treatment of Metastatic Melanoma in the ElderlyRino S. Seedor and Marlana Orloff, Current Oncology Reports, 3/22/2022
- Case Report: Cytarabine-Induced Pericarditis and Pericardial EffusionSato R., and Park, R., The Thomas Jefferson Medicine Forum, 2017
- Fatal Rituximab-Induced Nonspecific Interstitial Pneumonia: Case Report and Review of the LiteratureSato, R., Molligan J., and Gaballa, S., The Thomas Jefferson Medicine Forum, 2017
Abstracts/Posters
- The prevalence of hereditary pancreatitis mutations in families with pancreatic cancer.Seedor, R. S., Savage, M. J., Iqbal, W., Arora, S., Rainey, K., Forman, A., Lincoln, S., Garcia, J., Truty, R., Esplin, E. D., Handorf, E. A., and Hall, M. J., 2019 ASCO Annual Meeting.
- Clinical Trial in Progress: Phase II trial of defactinib (VS-6063) combined with VS-6766 (CH5126766) in patients with metastatic uveal melanoma.Seedor, R. S., Orloff, M., Gutkind, J. S., Aplin, A., Terai, M., Sharpe-Mills, E., Klose, H., Mastrangelo, M. J., and Sato, T., 2021 Virtual ASCO Annual Meeting, 6/4/2021
- Prospective study comparing self-administered geriatric assessment to provider’s routine clinical assessment of older patients with metastatic breast cancer treated at...Seedor, R. S., Meeker, C. R., Lewis, B., Handorf, E. A., Filchner, K. A., Winn, J., Goldstein, L. J., and Dotan, E., 2020 Virtual ASCO Annual Meeting, 5/29/2020
- Join now to see all
Other
- Germline Testing in Biliary Tract CancersSeedor, R.S., and Hall, M., ASCO Daily News
https://dailynews.ascopubs.org/do/10.1200/ADN.19.190399/full/.
9/5/2019
Press Mentions
- Metastatic Uveal Melanoma: New Drugs in Pipeline, but Prognoses Remain GrimDecember 14th, 2021
Hospital Affiliations
- Thomas Jefferson University HospitalPhiladelphia, Pennsylvania
- Saint Mary's HospitalWaterbury, Connecticut
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: